Literature DB >> 25050847

Peptic ulcer disease in Helicobacter pylori-infected children: clinical findings and mucosal immune response.

Caroll Hernández1, Carolina Serrano, Helly Einisman, Andrea Villagrán, Alfredo Peña, Ignacio Duarte, Javiera Torres, Francisca Riera, Paul R Harris.   

Abstract

OBJECTIVES: Peptic ulcer disease (PUD) is highly prevalent among adults but less common in children. Helicobacter pylori infection, the main cause of PUD, is, however, acquired extremely early in life. The aim of the study was to analyze clinical characteristics of children with PUD in a country with a high prevalence of the disease and to evaluate which host factors could determine this clinical outcome.
METHODS: Children referred for upper gastrointestinal (GI) endoscopy with suspicion of peptic diseases were included prospectively during an 8-year period. Antral biopsies were performed to determine H pylori presence and mucosal cytokines profile.
RESULTS: A total of 307 children between 3 and 18 years old were enrolled. Of the total, 237 children (46% boys) with complete data were included. H pylori infection was confirmed in 133 (56.1%) participants. Duodenal ulcer (DU) was diagnosed in 32 patients (13.5%); among them 29 were infected with H pylori (90.6%). Infected children had a nodular appearance of the gastric mucosa more often than noninfected children. Noninfected children had fewer lymphoid follicles and less inflammatory infiltrate than infected children. Only mucosal polymorphonuclear cell infiltration was more intense in DU-infected children as compared with non-DU-infected children. DU-infected children had higher levels of mucosal interferon-γ than noninfected and non-DU-infected patients. Non-DU-infected children had also higher levels of mucosal interleukin-10 than noninfected patients (P < 0.05).
CONCLUSIONS: PUD in children, especially DU, is strongly associated with H pylori infection in developing countries. There is no distinctive clinical presentation of children with PUD. T-helper cytokine balance may influence clinical outcomes in children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25050847     DOI: 10.1097/MPG.0000000000000500

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Therapy with omeprazole modulates regulatory T cell/T helper 17 immune response in children with duodenal ulcers.

Authors:  Chuan-Ying Li; Cheng Wu
Journal:  Inflammopharmacology       Date:  2017-07-22       Impact factor: 4.473

Review 2.  Comparative Immune Response in Children and Adults with H. pylori Infection.

Authors:  Alireza Razavi; Nader Bagheri; Fatemeh Azadegan-Dehkordi; Mahsa Shirzad; Ghorbanali Rahimian; Mahmoud Rafieian-Kopaei; Hedaytollah Shirzad
Journal:  J Immunol Res       Date:  2015-10-01       Impact factor: 4.818

3.  The characteristics of 83 giant peptic ulcers in Chinese children: Evaluation and follow-up.

Authors:  Zifei Tang; Jieru Shi; Min Ji; Peng Shi; Zhiheng Huang; Ying Huang
Journal:  Saudi J Gastroenterol       Date:  2018 Nov-Dec       Impact factor: 2.485

4.  Comparison of Helicobacter pylori stool antigen, salivary IgG, serum IgG, and serum IgM as diagnostic markers of H. pylori infection in children.

Authors:  Andy Darma; Bagus Samsu Tri Nugroho; Vinny Yoanna; Indah Sulistyani; Alpha Fardah Athiyyah; Reza Gunadi Ranuh; Subijanto Marto Sudarmo
Journal:  Iran J Microbiol       Date:  2019-06

5.  Helicobacter pylori Gastritis in Children-The Link between Endoscopy and Histology.

Authors:  Ana-Maria Teodora Domșa; Raluca Lupușoru; Dan Gheban; Radu Șerban; Cristina Maria Borzan
Journal:  J Clin Med       Date:  2020-03-13       Impact factor: 4.241

6.  Relationship between Helicobacter pylori cagA Genotypes Infection and IL-10 and TGFβ1 Genes' Expression in Gastric Epithelial Cells.

Authors:  Saeed Salavati; Manouchehr Ahmadi Hedayati; Amjad Ahmadi; Shohreh Fakhari; Ali Jalili
Journal:  Int J Prev Med       Date:  2020-02-17

7.  Gastroprotective effects of water extract of domesticated Amauroderma rugosum against several gastric ulcer models in rats.

Authors:  Yanzhen Mai; Siyuan Xu; Ru Shen; Bairu Feng; Hong He; Yifei Xu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.